SlideShare ist ein Scribd-Unternehmen logo
1 von 15
PHARMACEUTICALS




         PADMAKAR GUNTUR
         VAMSIDHAR M
         KRISHNA MUTTOJU
         PANKURI JAIN
         SWATI BAJAJ
         HIMA BINDHU
Insights
Within R&D there is need of superior innovation and
 lower costs which is achieved through:
   A comprehensive understanding of how the human
     body works at the molecular level.
    A much better grasp of the killer-effects from
     consumptions of drugs including side effects and
     intricacies caused
    Greater collaboration between the industry,
     academia, the regulators, governments and
     healthcare providers.
Insights….
Business Problem-1
• It is acknowledged that the pharmaceuticals industry has enormous
  expenditure in building a successful molecular composition in a time
  frame. R&D activity which is extensively outsourced predominantly
  occupies a great share of the incurred cost.
Analytical consultation
• Bench marking of the outsourced R&D
   – The R&D divisions per phase , per drug, per disease are benchmarked
     to indentify the best and the worst performing units resulting in the
      significant reduction of the outsourcing costs.

    – The analytical solution provides atleast a 40 %
      saving

                                                   100
                                                   80
                                   (in millions)
                                                   60
                                                   40
                                                   20
                                                     0
                                                         average R&D cost per unit Average cost after bench
                                                                                          marking

                                                                  Cost saved is 40%
Cost model
average Estimated cost for a molecule
composition                                      1 Billion $
average Number of phases                10
average number of R&D units per
phase                                   10
average cost /R&D unit                  10 M$
expected savings if the 4 least
performing units are stopped funding    40 M$
Estimated cost for benchmarking         0.3 M$
Projected price for providing this
analysis                                4 M$
Technical analysis For Benchmark

• DATA TYPE: Disease(cat), Drug(cat), Costs Incurred(neu),Cost, Time
  Period(neu), Number of Failures before successful experiment(neu), Team
  Size(neu), Successful/Failure Experiment (cat), R&D Firm(cat), R&D Firm
  Demographics(cat), R&D Firm Size(neu), etc

• DATA VOLUME: 20 to 40 input and output parameters

• IMPLEMENTATION: Quantify the level/positioning of each R&D Firm and
  identify top most firms for outsourcing.

• PROBLEM CLASS: Linear Optimization

• TECHNIQUE: DEA
Business Problem-2
 The formula of the created molecular composition many a time goes to
trash as the usage results many a side effect apart the suffering of patent
uniqueness.
Pharma Killer effects and patent tool
     (PAT -- Pharma analytic tool)
• The software tool that we would be providing would explain the pharma
  scientist the possible side effects and its intensity for a molecular
  composition.

• It also validates the formula for its uniqueness by checking with the patent
  database

• Maintenance and service is entertained for this tool.

• Based on the data generation, the tool would upgrade itself and provide
  the updated results.
Cost model for PAT
Domain understanding                               1 month
Collecting and processing of the data   3 months
Analysis and training                   3 months
Testing                                 2 months
Integration                             2 months
Design                                  1 months
Cost per hour                           80 $
Cost of the tool PAT                    0.6 M $

Support per hour                        60 $
Technical analysis for PAT
•   DATA TYPE: Disease(cat), Drug(cat), Molecule Composition(cat),Costs
    Incurred(neu), Time Period(neu), Number of Failures before successful
    experiment(neu), Side effects and/or Intricacies if any (cat)

•   DATA VOLUME: One Record for each type of molecule composition. Patent
    database.

•   IMPLEMENTATION: Given the molecule composition of a drug, to classify whether
    Side effects and/or Intricacies is caused or not. And if caused then which out of
    given Side effects and/or Intricacies categories. Patent search,

•   ERROR MEASURE: RECALL

•   PROBLEM CLASS: CLASSIFICATION

•   TECHNIQUE: DECISION TREE,NAÏVE BAYES, RANDOM FOREST, Page ranking, K-NN
    using HADOOP
PAT Framework
No of Rejected experiments at approval board
The tool saves the 40 % time wastage in killer experiments and
patent findings.




                                                             40%
      Time consumed




                      Killer experiments
International School of Engineering

                         2-56/2/19, Khanamet, Madhapur, Hyderabad - 500 081

                                                For Individuals: +91-9177585755 or 040-65743991
                                               For Corporates: +91-9618483483

                                                    Web: http://www.insofe.edu.in
                                             Facebook: http://www.facebook.com/insofe
                                                Twitter: https://twitter.com/INSOFEedu
                                              YouTube: http://www.youtube.com/InsofeVideos
                                             SlideShare: http://www.slideshare.net/INSOFE
                                              LinkedIn: http://www.linkedin.com/company/international-school-
                                                        of-engineering

This presentation may contain references to findings of various reports available in the public domain. INSOFE makes no representation as to their accuracy or that the
organization subscribes to those findings.

The best place for students to learn Applied Engineering                                                               http://www.insofe.edu.in

Weitere ähnliche Inhalte

Was ist angesagt?

Data mining in pharmacovigilance
Data mining in pharmacovigilanceData mining in pharmacovigilance
Data mining in pharmacovigilance
Bhaswat Chakraborty
 
METHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCEMETHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCE
Dr Arathy R Nath
 
Introduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal DetectionIntroduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal Detection
Perficient
 
Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...
Perficient
 
New drug application
New drug applicationNew drug application
New drug application
VKEkbote
 
Pharmaceutical Industry
Pharmaceutical IndustryPharmaceutical Industry
Pharmaceutical Industry
Nani Masters
 
Suppy chain management of pharma
Suppy chain management of pharmaSuppy chain management of pharma
Suppy chain management of pharma
Ankit Kankane
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
Shray Jali
 

Was ist angesagt? (20)

AI in Clinical Trials: From Big Sky to Practical Application
AI in Clinical Trials: From Big Sky to Practical ApplicationAI in Clinical Trials: From Big Sky to Practical Application
AI in Clinical Trials: From Big Sky to Practical Application
 
Data mining in pharmacovigilance
Data mining in pharmacovigilanceData mining in pharmacovigilance
Data mining in pharmacovigilance
 
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIAA REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
 
METHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCEMETHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCE
 
Introduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal DetectionIntroduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal Detection
 
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting   professor pirouziFda guidance for pharmaceutical post marketing reporting   professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
 
PSUR Requirements
PSUR RequirementsPSUR Requirements
PSUR Requirements
 
Post approval of drugs
Post approval of drugsPost approval of drugs
Post approval of drugs
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
 
Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...
 
DRUG MASTER FILE
DRUG MASTER FILEDRUG MASTER FILE
DRUG MASTER FILE
 
Indian pharmaceutical industry organisational structure & strategies
Indian pharmaceutical industry  organisational structure & strategiesIndian pharmaceutical industry  organisational structure & strategies
Indian pharmaceutical industry organisational structure & strategies
 
New drug application
New drug applicationNew drug application
New drug application
 
Medical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing SurvellianceMedical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing Survelliance
 
Pharmaceutical Industry
Pharmaceutical IndustryPharmaceutical Industry
Pharmaceutical Industry
 
Post Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & PharmacovigilancePost Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & Pharmacovigilance
 
Suppy chain management of pharma
Suppy chain management of pharmaSuppy chain management of pharma
Suppy chain management of pharma
 
Artificial Intelligence in Pharmaceutical Industry
Artificial Intelligence in Pharmaceutical IndustryArtificial Intelligence in Pharmaceutical Industry
Artificial Intelligence in Pharmaceutical Industry
 
Pharmaceutical Industry Global & Indian
Pharmaceutical Industry Global & IndianPharmaceutical Industry Global & Indian
Pharmaceutical Industry Global & Indian
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 

Andere mochten auch

Andere mochten auch (6)

Integrating Structure and Analytics with Unstructured Data
Integrating Structure and Analytics with Unstructured DataIntegrating Structure and Analytics with Unstructured Data
Integrating Structure and Analytics with Unstructured Data
 
Enabling Better Clinical Operations through a Clinical Operations Store
Enabling Better Clinical Operations through a Clinical Operations StoreEnabling Better Clinical Operations through a Clinical Operations Store
Enabling Better Clinical Operations through a Clinical Operations Store
 
Nursing informatics
Nursing informaticsNursing informatics
Nursing informatics
 
Leverage Big Data Analytics to Enhance Clinical Trials from Planning to Execu...
Leverage Big Data Analytics to Enhance Clinical Trials from Planning to Execu...Leverage Big Data Analytics to Enhance Clinical Trials from Planning to Execu...
Leverage Big Data Analytics to Enhance Clinical Trials from Planning to Execu...
 
Future of RWE - Big Data and Analytics for Pharma 2017 presentation
Future of RWE - Big Data and Analytics for Pharma 2017 presentationFuture of RWE - Big Data and Analytics for Pharma 2017 presentation
Future of RWE - Big Data and Analytics for Pharma 2017 presentation
 
Life Science Analytics
Life Science AnalyticsLife Science Analytics
Life Science Analytics
 

Ähnlich wie Analytics in Pharmaceutical Industry

Retrofitting a new process to an existing facility
Retrofitting a new process to an existing facilityRetrofitting a new process to an existing facility
Retrofitting a new process to an existing facility
GBX Summits
 
Platform Manufacturing.
Platform Manufacturing.Platform Manufacturing.
Platform Manufacturing.
Nazim Hussain
 

Ähnlich wie Analytics in Pharmaceutical Industry (20)

SMi Group's Pre-filled Syringes West Coast 2020 conference
SMi Group's Pre-filled Syringes West Coast 2020 conferenceSMi Group's Pre-filled Syringes West Coast 2020 conference
SMi Group's Pre-filled Syringes West Coast 2020 conference
 
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
Computational Modeling & Simulation in Orthopedics:  Tools to Comply in an Ev...Computational Modeling & Simulation in Orthopedics:  Tools to Comply in an Ev...
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
 
Retrofitting a new process to an existing facility
Retrofitting a new process to an existing facilityRetrofitting a new process to an existing facility
Retrofitting a new process to an existing facility
 
Nesher Tech I-Corps@NIH 121014
Nesher Tech I-Corps@NIH 121014Nesher Tech I-Corps@NIH 121014
Nesher Tech I-Corps@NIH 121014
 
Platform Manufacturing.
Platform Manufacturing.Platform Manufacturing.
Platform Manufacturing.
 
Resume
ResumeResume
Resume
 
IRJET- A New Hybrid Squirrel Search Algorithm and Invasive Weed Optimization ...
IRJET- A New Hybrid Squirrel Search Algorithm and Invasive Weed Optimization ...IRJET- A New Hybrid Squirrel Search Algorithm and Invasive Weed Optimization ...
IRJET- A New Hybrid Squirrel Search Algorithm and Invasive Weed Optimization ...
 
Res 10-30-15
Res 10-30-15Res 10-30-15
Res 10-30-15
 
Chinese Microfluidics Industry 2018 Report by Yole Developpement
Chinese Microfluidics Industry 2018 Report by Yole DeveloppementChinese Microfluidics Industry 2018 Report by Yole Developpement
Chinese Microfluidics Industry 2018 Report by Yole Developpement
 
Artificial Intelligence in Life Sciences and Agriculture.
Artificial Intelligence in Life Sciences and Agriculture.Artificial Intelligence in Life Sciences and Agriculture.
Artificial Intelligence in Life Sciences and Agriculture.
 
luxe research presentation at InnoCos Europe, Paris
luxe research presentation at InnoCos Europe, Parisluxe research presentation at InnoCos Europe, Paris
luxe research presentation at InnoCos Europe, Paris
 
Systems-Based Leadership Approach (SBLA) to Human Error in Pharmaceutical Man...
Systems-Based Leadership Approach (SBLA) to Human Error in Pharmaceutical Man...Systems-Based Leadership Approach (SBLA) to Human Error in Pharmaceutical Man...
Systems-Based Leadership Approach (SBLA) to Human Error in Pharmaceutical Man...
 
Project Report on Immunoassay Analyzer Manufacturing Plant
Project Report on Immunoassay Analyzer Manufacturing PlantProject Report on Immunoassay Analyzer Manufacturing Plant
Project Report on Immunoassay Analyzer Manufacturing Plant
 
2.pptx
2.pptx2.pptx
2.pptx
 
TouchED
TouchEDTouchED
TouchED
 
March 5, 2015 PoCDx Seminar - Wallace White, Stratos - Development of the Pan...
March 5, 2015 PoCDx Seminar - Wallace White, Stratos - Development of the Pan...March 5, 2015 PoCDx Seminar - Wallace White, Stratos - Development of the Pan...
March 5, 2015 PoCDx Seminar - Wallace White, Stratos - Development of the Pan...
 
Hazard and Operability Study (HAZOP) | Gaurav Singh Rajput
Hazard and Operability Study (HAZOP) | Gaurav Singh RajputHazard and Operability Study (HAZOP) | Gaurav Singh Rajput
Hazard and Operability Study (HAZOP) | Gaurav Singh Rajput
 
RCA on Residual defects – Techniques for adaptive Regression testing
RCA on Residual defects – Techniques for adaptive Regression testingRCA on Residual defects – Techniques for adaptive Regression testing
RCA on Residual defects – Techniques for adaptive Regression testing
 
Insect Repellent Manufacturing Project Report 2023 Edition
Insect Repellent Manufacturing Project Report 2023 EditionInsect Repellent Manufacturing Project Report 2023 Edition
Insect Repellent Manufacturing Project Report 2023 Edition
 
Prototyping
PrototypingPrototyping
Prototyping
 

Mehr von International School of Engineering

Mehr von International School of Engineering (18)

Decision Trees
Decision TreesDecision Trees
Decision Trees
 
Apriori Algorithm
Apriori AlgorithmApriori Algorithm
Apriori Algorithm
 
Engineering Big Data with Hadoop
Engineering Big Data with HadoopEngineering Big Data with Hadoop
Engineering Big Data with Hadoop
 
Scope and Career in Analytics
Scope and Career in AnalyticsScope and Career in Analytics
Scope and Career in Analytics
 
Part 6 (machine learning overview) what makes a problem tough continued
Part 6 (machine learning overview)   what makes a problem tough continuedPart 6 (machine learning overview)   what makes a problem tough continued
Part 6 (machine learning overview) what makes a problem tough continued
 
Part 5 (machine learning overview) what makes a problem tough
Part 5 (machine learning overview)   what makes a problem toughPart 5 (machine learning overview)   what makes a problem tough
Part 5 (machine learning overview) what makes a problem tough
 
Part 4 (machine learning overview) solution architecture
Part 4 (machine learning overview)   solution architecturePart 4 (machine learning overview)   solution architecture
Part 4 (machine learning overview) solution architecture
 
Part 3 (machine learning overview) the forms of knowledge
Part 3 (machine learning overview)   the forms of knowledgePart 3 (machine learning overview)   the forms of knowledge
Part 3 (machine learning overview) the forms of knowledge
 
Part 2 (machine learning overview) all machine learning is pattern search
Part 2 (machine learning overview)   all machine learning is pattern searchPart 2 (machine learning overview)   all machine learning is pattern search
Part 2 (machine learning overview) all machine learning is pattern search
 
Part 4 (machine learning overview) solution architecture
Part 4 (machine learning overview)   solution architecturePart 4 (machine learning overview)   solution architecture
Part 4 (machine learning overview) solution architecture
 
Part 3 (machine learning overview) the forms of knowledge
Part 3 (machine learning overview)   the forms of knowledgePart 3 (machine learning overview)   the forms of knowledge
Part 3 (machine learning overview) the forms of knowledge
 
Part 2 (machine learning overview) all machine learning is pattern search
Part 2 (machine learning overview)   all machine learning is pattern searchPart 2 (machine learning overview)   all machine learning is pattern search
Part 2 (machine learning overview) all machine learning is pattern search
 
Fast Track Machine Learning Part 1 (Machine Learning Overview) - Types of Mac...
Fast Track Machine Learning Part 1 (Machine Learning Overview) - Types of Mac...Fast Track Machine Learning Part 1 (Machine Learning Overview) - Types of Mac...
Fast Track Machine Learning Part 1 (Machine Learning Overview) - Types of Mac...
 
Service assurance with predictive analytics
Service assurance with predictive analyticsService assurance with predictive analytics
Service assurance with predictive analytics
 
Analytics in Supply Chain Management
Analytics in Supply Chain ManagementAnalytics in Supply Chain Management
Analytics in Supply Chain Management
 
Health Care Analytics
Health Care AnalyticsHealth Care Analytics
Health Care Analytics
 
Analytics in the Manufacturing industry
Analytics in the Manufacturing industryAnalytics in the Manufacturing industry
Analytics in the Manufacturing industry
 
Fraud detection
Fraud detectionFraud detection
Fraud detection
 

Analytics in Pharmaceutical Industry

  • 1. PHARMACEUTICALS PADMAKAR GUNTUR VAMSIDHAR M KRISHNA MUTTOJU PANKURI JAIN SWATI BAJAJ HIMA BINDHU
  • 2. Insights Within R&D there is need of superior innovation and lower costs which is achieved through:  A comprehensive understanding of how the human body works at the molecular level.  A much better grasp of the killer-effects from consumptions of drugs including side effects and intricacies caused  Greater collaboration between the industry, academia, the regulators, governments and healthcare providers.
  • 4. Business Problem-1 • It is acknowledged that the pharmaceuticals industry has enormous expenditure in building a successful molecular composition in a time frame. R&D activity which is extensively outsourced predominantly occupies a great share of the incurred cost.
  • 5. Analytical consultation • Bench marking of the outsourced R&D – The R&D divisions per phase , per drug, per disease are benchmarked to indentify the best and the worst performing units resulting in the significant reduction of the outsourcing costs. – The analytical solution provides atleast a 40 % saving 100 80 (in millions) 60 40 20 0 average R&D cost per unit Average cost after bench marking Cost saved is 40%
  • 6. Cost model average Estimated cost for a molecule composition 1 Billion $ average Number of phases 10 average number of R&D units per phase 10 average cost /R&D unit 10 M$ expected savings if the 4 least performing units are stopped funding 40 M$ Estimated cost for benchmarking 0.3 M$ Projected price for providing this analysis 4 M$
  • 7. Technical analysis For Benchmark • DATA TYPE: Disease(cat), Drug(cat), Costs Incurred(neu),Cost, Time Period(neu), Number of Failures before successful experiment(neu), Team Size(neu), Successful/Failure Experiment (cat), R&D Firm(cat), R&D Firm Demographics(cat), R&D Firm Size(neu), etc • DATA VOLUME: 20 to 40 input and output parameters • IMPLEMENTATION: Quantify the level/positioning of each R&D Firm and identify top most firms for outsourcing. • PROBLEM CLASS: Linear Optimization • TECHNIQUE: DEA
  • 8. Business Problem-2 The formula of the created molecular composition many a time goes to trash as the usage results many a side effect apart the suffering of patent uniqueness.
  • 9. Pharma Killer effects and patent tool (PAT -- Pharma analytic tool) • The software tool that we would be providing would explain the pharma scientist the possible side effects and its intensity for a molecular composition. • It also validates the formula for its uniqueness by checking with the patent database • Maintenance and service is entertained for this tool. • Based on the data generation, the tool would upgrade itself and provide the updated results.
  • 10. Cost model for PAT Domain understanding 1 month Collecting and processing of the data 3 months Analysis and training 3 months Testing 2 months Integration 2 months Design 1 months Cost per hour 80 $ Cost of the tool PAT 0.6 M $ Support per hour 60 $
  • 11. Technical analysis for PAT • DATA TYPE: Disease(cat), Drug(cat), Molecule Composition(cat),Costs Incurred(neu), Time Period(neu), Number of Failures before successful experiment(neu), Side effects and/or Intricacies if any (cat) • DATA VOLUME: One Record for each type of molecule composition. Patent database. • IMPLEMENTATION: Given the molecule composition of a drug, to classify whether Side effects and/or Intricacies is caused or not. And if caused then which out of given Side effects and/or Intricacies categories. Patent search, • ERROR MEASURE: RECALL • PROBLEM CLASS: CLASSIFICATION • TECHNIQUE: DECISION TREE,NAÏVE BAYES, RANDOM FOREST, Page ranking, K-NN using HADOOP
  • 13. No of Rejected experiments at approval board
  • 14. The tool saves the 40 % time wastage in killer experiments and patent findings. 40% Time consumed Killer experiments
  • 15. International School of Engineering 2-56/2/19, Khanamet, Madhapur, Hyderabad - 500 081 For Individuals: +91-9177585755 or 040-65743991 For Corporates: +91-9618483483 Web: http://www.insofe.edu.in Facebook: http://www.facebook.com/insofe Twitter: https://twitter.com/INSOFEedu YouTube: http://www.youtube.com/InsofeVideos SlideShare: http://www.slideshare.net/INSOFE LinkedIn: http://www.linkedin.com/company/international-school- of-engineering This presentation may contain references to findings of various reports available in the public domain. INSOFE makes no representation as to their accuracy or that the organization subscribes to those findings. The best place for students to learn Applied Engineering http://www.insofe.edu.in